barrett's disease - Viral Trends
Nasdaq: Castle Biosciences to Present New TissueCypher Test Data at Digestive Disease Week 2025, Highlighting Risk Stratification for Barrett's Esophagus Castle Biosciences to Present New TissueCypher Test Data at Digestive Disease Week 2025, Highlighting Risk Stratification for Barrett's Esophagus Medical Xpress: AI tool can predict Barrett's esophagus recurrence after therapy with 90% accuracy A new artificial intelligence (AI)-based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett's esophagus (BE)-related dysplasia and ... AI tool can predict Barrett's esophagus recurrence after therapy with 90% accuracy New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly esophageal cancer, to find effective strategies to identify patients with this ... Castle Biosciences will present TissueCypher Barrett’s Esophagus test data at DDW 2025, emphasizing risk stratification and personalized patient management.
Understanding the Context
Castle Biosciences, Inc. will present new ... News Medical: Study reveals how inherited genetic abnormalities raise Barrett’s esophagus risk